14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 29, 2024 Buy 0 Slebir John L Common Stock
Mar 29, 2024 Buy 300 000 Slebir John L Stock Option (Right to Buy)
Mar 29, 2024 Buy 80 000 Slebir John L Stock Options (Right to Buy)
Mar 29, 2024 Buy 50 000 Slebir John L Restricted Stock Unit
Mar 29, 2024 Buy 88 000 Slebir John L Stock Options (Right to Buy)
Mar 29, 2024 Buy 70 000 Slebir John L Stock Options (Right to Buy)
Mar 16, 2024 Buy 20 000 Burgess Justin Stock Options (Right to Buy)
Mar 01, 2024 Buy 2 767 Burgess Justin Common Stock
Mar 01, 2024 Buy 4 334 Burgess Justin Common Stock
Mar 01, 2024 Sell 7 101 Burgess Justin Common Stock
Mar 01, 2024 Sell 4 334 Burgess Justin Stock Options (Right to Buy)
Mar 01, 2024 Sell 2 767 Burgess Justin StockOptions (Right to Buy)
Mar 01, 2024 Sell 13 425 Burgess Justin Common Stock
Feb 16, 2024 Buy 6 667 Burgess Justin Common Stock
Feb 16, 2024 Sell 2 378 Burgess Justin Common Stock
Feb 16, 2024 Sell 6 667 Burgess Justin Restricted Stock Unit
Feb 15, 2024 Buy 95 000 Novack David F Stock Options (Right to Buy)
Feb 15, 2024 Buy 67 860 Novack David F Restricted Stock Unit
Feb 15, 2024 Buy 1 207 Novack David F Common Stock
Feb 15, 2024 Buy 231 000 Spencer Ryan Stock Options (Right to Buy)
Feb 15, 2024 Buy 402 Spencer Ryan Common Stock
Feb 15, 2024 Buy 165 000 Spencer Ryan Restricted Stock Unit
Feb 15, 2024 Buy 65 000 Macdonald Kelly Stock Options (Right to Buy)
Feb 15, 2024 Buy 46 430 Macdonald Kelly Restricted Stock Unit
Feb 15, 2024 Buy 50 000 Janssen Robert Stock Options (Right to Buy)
Feb 15, 2024 Buy 35 710 Janssen Robert Restricted Stock Unit
Feb 15, 2024 Buy 21 900 Burgess Justin Restricted Stock Unit
Feb 15, 2024 Buy 13 500 Burgess Justin Stock Options (Right to Buy)
Feb 12, 2024 Sell 3 151 Novack David F Common Stock
Feb 12, 2024 Sell 1 531 Janssen Robert Common Stock
Feb 12, 2024 Sell 11 684 Spencer Ryan Common Stock
Feb 12, 2024 Sell 2 499 Burgess Justin Common Stock
Feb 12, 2024 Sell 2 985 Macdonald Kelly Common Stock
Feb 10, 2024 Buy 8 833 Novack David F Common Stock
Feb 10, 2024 Sell 8 833 Novack David F Restricted Stock Unit
Feb 10, 2024 Buy 4 333 Janssen Robert Common Stock
Feb 10, 2024 Sell 4 333 Janssen Robert Restricted Stock Unit
Feb 10, 2024 Buy 20 833 Spencer Ryan Common Stock
Feb 10, 2024 Sell 20 833 Spencer Ryan Restricted Stock Unit
Feb 10, 2024 Buy 6 667 Burgess Justin Common Stock
Feb 10, 2024 Sell 6 667 Burgess Justin Restricted Stock Unit
Feb 10, 2024 Buy 5 333 Macdonald Kelly Common Stock
Feb 10, 2024 Sell 5 333 Macdonald Kelly Restricted Stock Unit
Feb 05, 2024 Sell 4 043 Janssen Robert Common Stock
Feb 05, 2024 Sell 6 688 Novack David F Common Stock
Feb 05, 2024 Sell 17 129 Spencer Ryan Common Stock
Feb 05, 2024 Sell 4 043 Janssen Robert Common Stock
Feb 05, 2024 Sell 3 448 Burgess Justin Common Stock
Feb 04, 2024 Buy 29 750 Spencer Ryan Common Stock
Feb 04, 2024 Sell 29 750 Spencer Ryan Restricted Stock Unit
Feb 03, 2024 Buy 17 500 Novack David F Common Stock
Feb 03, 2024 Sell 17 500 Novack David F Restricted Stock Unit
Feb 03, 2024 Buy 10 000 Janssen Robert Common Stock
Feb 03, 2024 Sell 10 000 Janssen Robert Restricted Stock Unit
Feb 03, 2024 Buy 8 416 Burgess Justin Common Stock
Feb 03, 2024 Sell 8 416 Burgess Justin Restricted Stock Unit
Jan 04, 2024 Buy 1 500 Janssen Robert Common Stock
Jan 04, 2024 Sell 1 500 Janssen Robert Common Stock
Jan 04, 2024 Sell 1 500 Janssen Robert Stock Option (Right to Buy)
Jan 02, 2024 Buy 9 000 Novack David F Common Stock
Jan 02, 2024 Sell 9 000 Novack David F Common Stock
Jan 02, 2024 Sell 9 000 Novack David F Stock Option (Right to Buy)
Dec 01, 2023 Buy 20 000 Novack David F Common Stock
Dec 01, 2023 Sell 20 000 Novack David F Stock Option (Right to Buy)
Dec 01, 2023 Sell 20 000 Novack David F Common Stock
Nov 03, 2023 Sell 20 000 Novack David F Stock Option (Right to Buy)
Nov 03, 2023 Buy 20 000 Novack David F Common Stock
Nov 03, 2023 Sell 20 000 Novack David F Common Stock
Nov 01, 2023 Sell 20 000 Novack David F Stock Option (Right to Buy)
Nov 01, 2023 Buy 20 000 Novack David F Common Stock
Nov 01, 2023 Sell 20 000 Novack David F Common Stock
Oct 10, 2023 Buy 1 755 Janssen Robert Common Stock
Oct 10, 2023 Sell 1 755 Janssen Robert Common Stock
Oct 10, 2023 Sell 1 755 Janssen Robert Stock Option (Right to Buy)
Oct 02, 2023 Sell 40 000 Novack David F Stock Option (Right to Buy)
Oct 02, 2023 Buy 40 000 Novack David F Common Stock
Oct 02, 2023 Sell 20 000 Novack David F Common Stock
Oct 02, 2023 Sell 20 000 Novack David F Common Stock
Oct 02, 2023 Buy 5 015 Janssen Robert Common Stock
Oct 02, 2023 Sell 5 015 Janssen Robert Common Stock
Oct 02, 2023 Sell 5 015 Janssen Robert Stock Option (Right to Buy)
Sep 01, 2023 Sell 20 000 Novack David F Stock Option (Right to Buy)
Sep 01, 2023 Buy 20 000 Novack David F Common Stock
Sep 01, 2023 Sell 20 000 Novack David F Common Stock
Aug 24, 2023 Buy 600 Janssen Robert Common Stock
Aug 24, 2023 Sell 600 Janssen Robert Common Stock
Aug 24, 2023 Sell 600 Janssen Robert Stock Option (Right to Buy)
Aug 23, 2023 Buy 34 857 Janssen Robert Common Stock
Aug 23, 2023 Sell 34 857 Janssen Robert Common Stock
Aug 23, 2023 Sell 34 857 Janssen Robert Stock Option (Right to Buy)
Aug 08, 2023 Sell 1 500 000 Hack Andrew A. F. Common Stock
Aug 08, 2023 Sell 15 000 Novack David F Stock Option (Right to Buy)
Aug 08, 2023 Buy 15 000 Novack David F Common Stock
Aug 08, 2023 Sell 10 000 Novack David F Common Stock
Aug 08, 2023 Buy 25 000 Novack David F Common Stock
Aug 08, 2023 Sell 10 000 Novack David F Common Stock
Aug 08, 2023 Sell 20 000 Novack David F Common Stock
Aug 08, 2023 Sell 25 000 Novack David F Stock Option (Right to Buy)
Aug 08, 2023 Sell 2 600 Janssen Robert Stock Option (Right to Buy)
Aug 08, 2023 Buy 2 600 Janssen Robert Common Stock
INSIDER POWER
3.213
Last 100 transactions
Buy: 1 741 769 | Sell: 2 133 592 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 3.213.

In total, the insiders bought 1 741 769 and sold 2 133 592 DVAX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT